C5 and paroxysmal nocturnal hemoglobinuria: Proximal complement inhibitors targeting C3, factor B, or factor D may overcome EVH in affected PNH patients [6–8] as these agents have a greater potential to spare GPI- deficient erythrocytes from complement-mediated destruction compared to C5 inhibitors.